FDA approves Eli Lilly’s diabetes drug Zepbound; production underway in Durham
The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.
Read More
